Are you a road rage risk? Ask yourself these questions:
Are you a road rage risk? Ask yourself these questions:
Johannesburg – Every day we see videos published online showing motorists 'losing it' and getting into physical altercations; recently a confrontation between a Johannesburg Metro Police Department officer and a taxi driver made headlines, while a shooting incident, allegedly over a parking spot, left a Pietermaritzburg motorist dead and his passenger critically injured. Incidents like these are becoming both more frequent and more violent as South Africans get increasingly stressed out by congested traffic in all our major cities, as well as life's demands, both personal and professional.
Positive Phase III Results for Genentech’s HEMLIBRA (emicizumab-kxwh) for Hemophilia A Without Factor VIII Inhibitors Published in New England Journal of Medicine:
Aug 30, 2018–Genentech, a member of the Roche Group , announced today that pivotal data from the Phase III HAVEN 3 study, which evaluated HEMLIBRA A prophylaxis administered every week or every two weeks in adults and adolescents aged 12 years or older with hemophilia A without factor VIII inhibitors, were published in the August 30, 2018, issue of the New England Journal of Medicine . “In the HAVEN 3 study, HEMLIBRA showed a significant and clinically meaningful reduction in bleeds in people with hemophilia A without factor VIII inhibitors, while offering multiple subcutaneous dosing options,” said Dr. Johnny Mahlangu, Faculty of Health Sciences, University of the Witwatersrand and NHLS, Johannesburg, South Africa.
Click HERE to submit your Johannesburg or Gauteng Press Release to MyPR.co.za.
News from Africa:
Source: MyJHB
Read more on MyJHB.
Join the fun: Add Your event | Submit a Press Release | Add your listing.
